Funding Sources

COVID-19 Funding Opportunities

There are many emerging funding opportunities for COVID-19 research, which we are listing here.  Please check this site regularly, and if you have any questions, our Office of Research Support Services is available.  In addition, the NIH created this helpful overview for applicants and recipients of NIH funding related to COVID-19.

If there is an opportunity you would like to pursue, please email Michael Ostap at ostap@pennmedicine.upenn.edu, and we will work to coordinate researchers and resources to best support your application.


National Institutes of Health (NIH)

(Dated August 7, 2020) The NIH released several new COVID-related RFAs over the past week.  Many of these are part of the “Rapid Acceleration of Diagnostics (RADX)” initiative:  https://www.nih.gov/research-training/medical-research-initiatives/radx . These new releases focus on data collection, sensing devices for detecting volatile compounds (electronic nose), wastewater testing, real-time testing using electronic touchscreens, as well as others. 

Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)

Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)

Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)

Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)

Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)

Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)

Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)

Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)

Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed)

Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19).

Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)

Notice to Clarify and Correct Eligibility in Notices of Special Interest under the Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) Program

Amazon Diagnostic Development Initiative

 American Heart Association (AHA)

American Lung Association

Biomedical Advanced Research and Development Authority (BARDA)

California Institute for Regenerative Medicine (CIRM)

Coalition for Epidemic Preparedness Innovation (CEPI)

  • Calls for proposals to accelerate the development of vaccines against emerging infectious diseases.

Covent-19 Ventilator Challenge

  •  Innovate2Ventilate: An Open Innovation Effort to Design a Rapidly Deployable Mechanical Ventilator

 Department of Defense (DOD)

Gates Foundation

Harrington Discovery Institute

Medical Countermeasures

National Science Foundation (NSF)

Patient Centered Outcomes Research Institute

Robert Wood Johnson Foundation

Roddenberry Foundation

  • Roddenberry Prize: An effort to crowdsource innovative solutions to issues that demand audacious, far-reaching, and scalable responses.

    Image Credit: CDC.